P2 has assembled an executive team with strong backgrounds in technology, markets and financing. In addition the shareholder group and advisory board provide a solid platform to support growth.
Executive Team
Chairman – Rob Bettigole
- Founder and Managing Partner of Elm Street Ventures
- Board member/observer at a range of companies including Affomix Corporation, BioRelix, Inc., Samara Innovations, ShareGrove, Occam Pharma
- B.S. in Engineering & Applied Science from Yale University; MPPM from the Yale School of Management
CEO – Neil Burns
- 20 years surfactant experience in commercial, financial and general management
- Managing Partner, Neil A. Burns LLC, investment and advisory firm.
- Former CEO of Oxiteno USA, the US subsidiary of Ultrapar of Brazil
- B.S. Chemistry, MBA (Wharton)
Chief Scientific Officer – Patrick Foley
- PhD (ABD) Environmental Engineering, Yale University
- B.S. Molecular Biology, University of Connecticut
- Discovery Research, Pfizer (2004-2008)
Research Director – Matthew Dunn
- Project Leader, Pfizer
- Research Chemist, Inframat
- M.Sc. Organic Chemistry, University of Connecticut
Share Holders
In addition to co-founders and key employees, P2′s Shareholders include:
Elm Street Ventures
- An early stage investment fund based in New Haven, CT
- Focused on Life Sciences, Cleantech
- www.elmvc.com
Yale University
- Leading US teaching and Research University
- www.yale.edu